Disclosed positions

Estimated from their latest filings — positions may have changed since

$5.60M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ADPTAdaptive Biotechnologies Corp	256,725	$21.80	$5.60M	100%	2026-05-18

ADPT

Adaptive Biotechnologies Corp

$5.60M

256,725 sh

All filings on record

Every Form 4 transaction we track for this filer

all 10buys 0sells 5

Stock	Transaction	Date	~6mo later
ADPTAdaptive Biotechnologies Corp	Sell $40.6K · 3,115 sh	2026-05-18	—
ADPTAdaptive Biotechnologies Corp	Sell $39.6K · 2,145 sh	2026-02-04	—
ADPTAdaptive Biotechnologies Corp	Exercise $26.0K · 2,145 sh	2026-02-04	—
ADPTAdaptive Biotechnologies Corp	Sell $77.2K · 4,290 sh	2026-01-12	—
ADPTAdaptive Biotechnologies Corp	Exercise $52.1K · 4,290 sh	2026-01-12	—
ADPTAdaptive Biotechnologies Corp	Sell $3.17M · 162,820 sh	2025-11-28	—
ADPTAdaptive Biotechnologies Corp	Exercise $1.15M · 94,384 sh	2025-11-28	—
ADPTAdaptive Biotechnologies Corp	Exercise $29.3K · 3,750 sh	2025-11-28	—
ADPTAdaptive Biotechnologies Corp	Exercise $78.5K · 11,980 sh	2025-11-28	—
ADPTAdaptive Biotechnologies Corp	Sell $3.3K · 238 sh	2025-11-17	—

ADPTSell

2026-05-18 · Adaptive Biotechnologies Corp

$40.6K

—

ADPTSell

2026-02-04 · Adaptive Biotechnologies Corp

$39.6K

—

ADPTExercise

2026-02-04 · Adaptive Biotechnologies Corp

$26.0K

—

ADPTSell

2026-01-12 · Adaptive Biotechnologies Corp

$77.2K

—

ADPTExercise

2026-01-12 · Adaptive Biotechnologies Corp

$52.1K

—

ADPTSell

2025-11-28 · Adaptive Biotechnologies Corp

$3.17M

—

ADPTExercise

2025-11-28 · Adaptive Biotechnologies Corp

$1.15M

—

ADPTExercise

2025-11-28 · Adaptive Biotechnologies Corp

$29.3K

—

ADPTExercise

2025-11-28 · Adaptive Biotechnologies Corp

$78.5K

—

ADPTSell

2025-11-17 · Adaptive Biotechnologies Corp

$3.3K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.